Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage
SCS-ICH
The Safety and Efficacy of Short-term Cervical Spinal Cord Stimulation in Patients With Disorders of Consciousness After Intracerebral Hemorrhage: a Multicenter, Prospective, Randomized, Outcome-blind Interventional Study
1 other identifier
interventional
344
1 country
1
Brief Summary
Disorders of consciousness (DOC) refers to the persistent loss of consciousness after 28 days in patients with brain injury caused by trauma, stroke, or hypoxia. It includes coma, vegetative state, and minimally conscious state. At present, there is no effective treatment for DOC. Only one RCT study of amantadine has proved that it may be effective for the treatment of DOC. In recent years, more evidence has shown that neuromodulation technology is beneficial to the recovery of DOC. Cervical spinal cord stimulation surgery is a new treatment method for patients with DOC. Electrodes are implanted in the high cervical spinal cord C2-C5. By adjusting different electrical stimulation parameters, it has a wake-promoting effect. In this study, patients were selected into the spinal cord stimulation group and the conventional treatment group according to the wishes of their families. The patients in the spinal cord stimulation group were given 21 days of cervical spinal cord stimulation treatment on the basis of conventional brain rehabilitation. Patients were followed up routinely and completed designated examinations at 12 months to determine the safety and efficacy of cervical spinal cord stimulation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 25, 2023
CompletedFirst Posted
Study publicly available on registry
June 28, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2030
July 3, 2023
June 1, 2023
3.2 years
May 25, 2023
June 28, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in consciousness 12 months after surgery assessed by CRS-R
The primary efficacy indicator is "change in consciousness recovery 12 months after cervical spinal cord electrical stimulation (assessed by the Coma Recovery Scale - Revised (CRS-R), ranges from 0 to 25, with higher scores mean a better outcome)".
12 months
Secondary Outcomes (1)
Consciousness recovery 12 months after surgery assessed by GOS-E
12 months
Other Outcomes (4)
Glasgow Coma Scale (GCS)
12 months
National Institute of Health stroke scale (NIHSS)
12 months
Full Outline of UnResponsiveness (FOUR) Score
12 months
- +1 more other outcomes
Study Arms (2)
Spinal cord electrical stimulation group
EXPERIMENTALAccording to the EDC system, patients are randomly assigned to receive 21 days of cervical spinal cord electrical stimulation treatment in addition to routine brain resuscitation and rehabilitation awakening treatment.
Conventional treatment group
SHAM COMPARATORAccording to the EDC system, patients are randomly assigned to receive only routine brain resuscitation and rehabilitation awakening treatment.
Interventions
21 days of cervical spinal cord electrical stimulation treatment in addition to routine brain resuscitation and rehabilitation awakening treatment.
Routine brain resuscitation and rehabilitation awakening treatment.
Eligibility Criteria
You may qualify if:
- Age between 18 and 65 years old
- Patients with postoperative consciousness disorders after cerebral hemorrhage for more than 28 days
- CRS-R score meets the MCS diagnosis
- Signed informed consent.
You may not qualify if:
- Secondary brain injury caused by arteriovenous malformation, cerebral aneurysm, cavernous hemangioma, brain tumor and carbon monoxide poisoning
- History of previous epileptic seizures
- Critical condition, unstable intracranial condition, risk of rebleeding
- Unstable vital signs requiring mechanical ventilation
- Contraindications for spinal cord surgery
- Severe sympathetic overactivity syndrome.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- director
Study Record Dates
First Submitted
May 25, 2023
First Posted
June 28, 2023
Study Start
July 1, 2023
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2030
Last Updated
July 3, 2023
Record last verified: 2023-06